Who
Mohamed Zaki
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, ADC Therapeutics SA.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Dec 2024
- Last trade
- 30 Jun 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 2 Jul 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —213,900 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —213,900 at $0.00 | filing |
| 13 Feb 2026filed 18 Feb 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | $1.1M285,200 at $3.99 | filing |
| 13 Feb 2026filed 18 Feb 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $98K24,603 at $3.99 | filing |
| 13 Feb 2026filed 18 Feb 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | $1.1M285,200 at $3.99 | filing |
| 13 Feb 2026filed 18 Feb 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $98K24,603 at $3.99 | filing |
| 6 Dec 2025filed 9 Dec 2025 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $135K41,068 at $3.29 | filing |
| 13 Feb 2025filed 14 Feb 2025 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | $370K230,000 at $1.61 | filing |
| 6 Dec 2024filed 9 Dec 2024 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $116K37,112 at $3.13 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.